Rocchina Colucci Selected Research

2,4-dinitrobenzenesulfonic acid

6/2021	Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.
2/2015	An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis.
1/2014	Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats.
1/2011	Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis.
11/2010	The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors.
8/2007	Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.
6/2006	Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation.
2/2006	A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rocchina Colucci Research Topics

Disease

25	Inflammation (Inflammations) 10/2021 - 05/2003
10	Colitis 06/2021 - 05/2003
9	Obesity 10/2021 - 12/2017
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 04/2008
4	Pain (Aches) 02/2009 - 01/2006
3	Fibrosis (Cirrhosis) 10/2018 - 02/2015
3	Body Weight (Weight, Body) 01/2018 - 08/2007
3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2013 - 12/2003
3	Stomach Ulcer (Gastric Ulcer) 07/2012 - 03/2009
3	Ulcer 07/2012 - 03/2009
3	Wounds and Injuries (Trauma) 06/2012 - 07/2005
2	Neoplasms (Cancer) 10/2016 - 09/2014
2	Hemorrhage 02/2016 - 06/2009
2	Peptic Ulcer (Peptic Ulcers) 02/2009 - 01/2008
1	Alzheimer Disease (Alzheimer's Disease) 05/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Necrosis 12/2019
1	Morbid Obesity 01/2019
1	Chronic Disease (Chronic Diseases) 12/2018
1	Parkinson Disease (Parkinson's Disease) 02/2016
1	Neoplasm Metastasis (Metastasis) 09/2014
1	Essential Hypertension 10/2013
1	Sepsis (Septicemia) 06/2012
1	Lung Diseases (Lung Disease) 06/2012
1	Rheumatoid Arthritis 06/2012

Drug/Important Bio-Agent (IBA)

9	Adenosine (Adenocard)FDA LinkGeneric 09/2014 - 02/2006
8	2,4-dinitrobenzenesulfonic acidIBA 06/2021 - 02/2006
8	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 07/2005
6	2,4-dinitrofluorobenzene sulfonic acidIBA 06/2021 - 05/2003
5	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020 - 04/2008
5	CytokinesIBA 12/2019 - 08/2007
4	Pharmaceutical PreparationsIBA 06/2021 - 02/2006
4	Dexamethasone (Maxidex)FDA LinkGeneric 06/2021 - 08/2007
4	Proteins (Proteins, Gene)FDA Link 05/2020 - 02/2016
4	Cholinergic Agents (Cholinergics)IBA 02/2016 - 05/2003
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2013 - 02/2005
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2012 - 02/2005
4	Protein Isoforms (Isoforms)IBA 07/2012 - 02/2005
3	InflammasomesIBA 01/2020 - 01/2018
3	CollagenIBA 01/2020 - 02/2015
3	Superoxides (Superoxide)IBA 10/2018 - 02/2009
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2016 - 03/2009
3	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2013 - 12/2003
3	Adenosine DeaminaseIBA 06/2012 - 08/2007
3	AcidsIBA 01/2011 - 05/2003
2	NucleotidesIBA 01/2020 - 01/2018
2	Leucine (L-Leucine)FDA Link 01/2020 - 01/2018
2	ApigeninIBA 12/2019 - 01/2018
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 01/2019
2	ArginaseIBA 01/2019 - 10/2018
2	AntioxidantsIBA 12/2018 - 01/2018
2	FlavonoidsIBA 12/2018 - 01/2018
2	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2018 - 07/2011
2	Diclofenac (SR 38)FDA LinkGeneric 01/2018 - 07/2005
2	Malondialdehyde (Propanedial)IBA 02/2016 - 03/2009
2	Purinergic Receptors (Receptors, Purine)IBA 01/2014 - 04/2008
2	Caspase 3 (Caspase-3)IBA 07/2012 - 03/2009
2	SC 560IBA 07/2012 - 06/2006
2	Acetic Acid (Vinegar)FDA LinkGeneric 07/2012 - 03/2009
2	ProstaglandinsIBA 07/2012 - 02/2005
2	Indomethacin (Indometacin)FDA LinkGeneric 07/2012 - 03/2009
2	EnzymesIBA 06/2012 - 04/2008
2	Proton Pump InhibitorsIBA 01/2011 - 03/2009
2	pyrimidineIBA 11/2010 - 08/2007
2	9-(2-hydroxy-3-nonyl)adenine (EHNA)IBA 11/2010 - 08/2007
2	pyrazoleIBA 11/2010 - 08/2007
2	Paroxetine (Paxil)FDA LinkGeneric 07/2010 - 06/2009
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2006 - 03/2005
2	Dinoprostone (PGE2)FDA Link 01/2006 - 02/2005
1	Substance PIBA 10/2021
1	CholesterolIBA 10/2021
1	AMP-Activated Protein KinasesIBA 06/2021
1	acadesineIBA 06/2021
1	Endothelin-1 (Endothelin 1)IBA 01/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	Biological ProductsIBA 12/2018
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 10/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018
1	N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketoneIBA 01/2018
1	LuteolinIBA 01/2018
1	Caspase 1 (ICE Protease)IBA 01/2018
1	dinitrobenzenesulfonic acidIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Fibronectins (Fibronectin)IBA 10/2016
1	DesminIBA 10/2016
1	VimentinIBA 10/2016
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 10/2016
1	NestinIBA 10/2016
1	Peroxidase (Myeloperoxidase)IBA 02/2016
1	Hemoglobins (Hemoglobin)IBA 02/2016
1	LipidsIBA 02/2016
1	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateIBA 01/2014
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2013
1	valdecoxib (Bextra)FDA Link 07/2012
1	Celecoxib (Celebrex)FDA Link 07/2012
1	Prostaglandins EIBA 07/2012
1	Cyclooxygenase InhibitorsIBA 07/2012